Literature DB >> 9800146

Retention in treatment of heroin users in Italy: the role of treatment type and of methadone maintenance dosage.

D D'Ippoliti1, M Davoli, C A Perucci, F Pasqualini, A M Bargagli.   

Abstract

Retention in treatment among 1503 heroin users attending public treatment centres in 1995 was studied. Three different treatments were considered: methadone maintenance, drug-free program and naltrexone. The retention rate after 1 year was 40% for patients in methadone maintenance, 18% in naltrexone and 15% in drug-free program. For patients in maintenance, methadone dosage and clinic policy were the most important factors for retention. Patients taking > or = 60 mg/day and 30-59 mg/day were respectively 70 and 50% more likely to remain in treatment than those receiving a < 30 mg daily dose. Patients in maintenance-oriented clinics were 30% more likely to remain in treatment than those in abstinence-oriented centres.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9800146     DOI: 10.1016/s0376-8716(98)00091-x

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  17 in total

1.  Health policies on drug dependence must be based on scientific evidence.

Authors:  Marina Davoli; Marica Ferri; Carlo A Perucci; Alessandro Liberati
Journal:  BMJ       Date:  2002-06-01

Review 2.  Office-based maintenance treatment of opioid dependence: how does it compare with traditional approaches?

Authors:  Erik W Gunderson; David A Fiellin
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

3.  Adherence to and Retention in Medications for Opioid Use Disorder Among Adolescents and Young Adults.

Authors:  Adam Viera; Daniel J Bromberg; Shannon Whittaker; Bryan M Refsland; Milena Stanojlović; Kate Nyhan; Frederick L Altice
Journal:  Epidemiol Rev       Date:  2020-01-31       Impact factor: 6.222

4.  Correlates of methadone client retention: a prospective cohort study in Guizhou province, China.

Authors:  Enwu Liu; Tao Liang; Limei Shen; Huan Zhong; Bing Wang; Zunyou Wu; Roger Detels
Journal:  Int J Drug Policy       Date:  2008-10-31

5.  Knowledge and Attitudes About Methadone Maintenance Among Staff Working in a Therapeutic Community.

Authors:  Siara Andrews; James L Sorensen; Joseph Guydish; Kevin Delucchi; Brian Greenberg
Journal:  J Maint Addict       Date:  2008-10-24

6.  Staff attitudes and the associations with treatment organisation, clinical practices and outcomes in opioid maintenance treatment.

Authors:  Linn Gjersing; Helge Waal; John R M Caplehorn; Michael Gossop; Thomas Clausen
Journal:  BMC Health Serv Res       Date:  2010-07-06       Impact factor: 2.655

7.  Does methadone maintenance treatment based on the new national guidelines work in a primary care setting?

Authors:  Jenny Keen; Phillip Oliver; Georgina Rowse; Nigel Mathers
Journal:  Br J Gen Pract       Date:  2003-06       Impact factor: 5.386

8.  Does naltrexone treatment lead to depression? Findings from a randomized controlled trial in subjects with opioid dependence.

Authors:  Angela J Dean; John B Saunders; Rod T Jones; Ross M Young; Jason P Connor; Bruce R Lawford
Journal:  J Psychiatry Neurosci       Date:  2006-01       Impact factor: 6.186

9.  Contribution of the activities of CYP3A, CYP2D6, CYP1A2 and other potential covariates to the disposition of methadone in patients undergoing methadone maintenance treatment.

Authors:  Mohammad-Reza Shiran; Martin S Lennard; Mohammad-Zafar Iqbal; Oldwale Lagundoye; Nicholas Seivewright; Geoffrey T Tucker; Amin Rostami-Hodjegan
Journal:  Br J Clin Pharmacol       Date:  2009-01       Impact factor: 4.335

10.  Problem drug use the public health imperative: what some of the literature says.

Authors:  Gez Bevan
Journal:  Subst Abuse Treat Prev Policy       Date:  2009-12-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.